Physician profile
Nahed K Bolis
NPI 1952577652
$1,077.68
in general payments reported to CMS, 2019-2025
15 companies · $15.36 in 2025
The $15.36 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.88 · 2020: $130 · 2021: $212 · 2022: $499 · 2023: $123 · 2024: $68.13 · 2025: $15.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $491.60 | 2021-2025 | Nuzyra |
| Horizon Therapeutics Plc | $114.35 | 2020-2021 | |
| Organogenesis INC. | $107.99 | 2022-2023 | Puraply |
| Grt US Holding, INC. | $89.83 | 2022 | |
| Heron Therapeutics, INC. | $72.47 | 2022 | |
| Nevro Corp. | $33.84 | 2022-2024 | Senza |
| Melinta Therapeutics, LLC | $29.88 | 2019 | |
| Integra Lifesciences Corporation | $28.03 | 2020 | |
| Triad Life Sciences INC. | $22.09 | 2022 | |
| Hartmann USA, INC. | $17.85 | 2021 | |
| Smith+Nephew, INC. | $16.43 | 2024 | Renasys Touch |
| Orthofix Medical, INC. | $15.62 | 2021 | |
| Medtronic, INC. | $15.47 | 2022 | |
| Bioventus LLC | $11.14 | 2020 | |
| Ermi LLC | $11.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nahed Bolis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.